White House News First 10 Drugs Chosen For Medicare Price Negotiations Healio
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, White House News First 10 Drugs Chosen For Medicare Price Negotiations Healio is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
New 2026 price negotiations: What the first cuts on high-cost drugs mean for pharmacies
Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, bringing major changes for pharmacies, insurers, and beneficiaries. Read More
Trump administration announces lower prices for 15 drugs, including Ozempic, in second round of Medicare negotiations
Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price. Read More
Medicare beneficiaries expected to save $685M from drug price negotiations
The Centers for Medicare and Medicaid Services has announced the expected savings from a second round of Medicare drug price negotiations. There is a net savings of 44%, or $12 billion, from ... Read More
Trump admin says drug price negotiations will save Medicare roughly $12 billion
Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ... Read More
Medicare cuts prices for 15 prescription drugs. Here's what they are
Medicare has negotiated list price reductions of up to 85% for 15 widely used drugs in the program, including Novo Nordisk's blockbuster GLP-1 drug Ozempic, officials announced Tuesday. Why it matters ... Read More
Trump’s drug pricing push sidelines Medicare negotiation program
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ... Read More
Medicare announces lower prices for 15 drugs including Ozempic, Wegovy
The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription drugs, including popular weight-loss medications Ozempic and Wegovy, asthma ... Read More
Medicare negotiates discounts on two AbbVie drugs
The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus